5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease.

Both low and high dose IR 5-ALA treatments recorded lower DAI scores than the IR 5-ASA treatment (group 9) on day 10; however, these results did not reach statistical significance. 3.2.2.

also in 111,027 other papers